Clinical Methods and Design for a Phase II Randomised Control Trial to Assess the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in Idiopathic Intracranial Hypertension: IIH:DT
- Keira Markey
- , Ryan Ottridge
- , James Mitchell
- , Caroline Rick
- , Rebecca Woolley
- , Natalie Ives
- , Peter Nightingale
- , Alexandra Sinclair
Research output: Contribution to journal › Article › peer-review
374
Downloads
(Pure)